Tower Research Capital (TRC)’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-9,173
| Closed | -$16K | – | 4671 |
|
|
2016
Q4 | $16K | Buy |
9,173
+3,707
| +68% | +$6.47K | ﹤0.01% | 2358 |
|
|
2016
Q3 | $18K | Buy |
5,466
+2,546
| +87% | +$8.38K | ﹤0.01% | 1704 |
|
|
2016
Q2 | $13K | Sell |
2,920
-748
| -20% | -$3.33K | ﹤0.01% | 2634 |
|
|
2016
Q1 | $21K | Buy |
3,668
+3,659
| +40,656% | +$20.9K | ﹤0.01% | 1327 |
|
|
2015
Q4 | $0 | Buy |
+9
| New | – | ﹤0.01% | 5801 |
|
|
2015
Q3 | – | Sell |
-2,256
| Closed | -$111K | – | 5757 |
|
|
2015
Q2 | $111K | Sell |
2,256
-2,614
| -54% | -$129K | 0.01% | 723 |
|
|
2015
Q1 | $382K | Buy |
+4,870
| New | +$382K | 0.05% | 206 |
|
|
2014
Q4 | – | Sell |
-30
| Closed | -$1K | – | 5580 |
|
|
2014
Q3 | $1K | Sell |
30
-93
| -76% | -$3.1K | ﹤0.01% | 4337 |
|
|
2014
Q2 | $8K | Buy |
123
+53
| +76% | +$3.45K | ﹤0.01% | 2583 |
|
|
2014
Q1 | $5K | Buy |
+70
| New | +$5K | ﹤0.01% | 3386 |
|
|
2013
Q4 | – | Sell |
-859
| Closed | -$53K | – | 5534 |
|
|
2013
Q3 | $53K | Buy |
+859
| New | +$53K | 0.01% | 1876 |
|